Liu Shu-Tsen, Lin Sheng-Che, Chang Jane Pei-Chen, Yang Kai-Jie, Chu Che-Sheng, Yang Chia-Chun, Liang Chih-Sung, Sun Ching-Fang, Wang Shao-Cheng, Satyanarayanan Senthil Kumaran, Su Kuan-Pin
Division of Child and Adolescent Psychiatry & Division of Developmental and Behavioral Pediatrics, China Medical University Children's Hospital, Taichung, Taiwan.
An-Nan Hospital, China Medical University, Tainan, Taiwan.
Clin Psychopharmacol Neurosci. 2023 Feb 28;21(1):10-18. doi: 10.9758/cpn.2023.21.1.10.
There is growing evidence that the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with increased risks of psychiatric sequelae. Depression, anxiety, cognitive impairments, sleep disturbance, and fatigue during and after the acute phase of COVID-19 are prevalent, long-lasting, and exerting negative consequences on well-being and imposing a huge burden on healthcare systems and society. This current review presented timely updates of clinical research findings, particularly focusing on the pathogenetic mechanisms underlying the neuropsychiatric sequelae, and identified potential key targets for developing effective treatment strategies for long COVID. In addition, we introduced the Formosa Long COVID Multicenter Study (FOCuS), which aims to apply the inflammation theory to the pathogenesis and the psychosocial and nutrition treatments of post-COVID depression and anxiety.
越来越多的证据表明,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的2019冠状病毒病(COVID-19)与精神后遗症风险增加有关。COVID-19急性期期间及之后出现的抑郁、焦虑、认知障碍、睡眠障碍和疲劳很常见,且持续时间长,会对幸福感产生负面影响,并给医疗系统和社会带来巨大负担。本综述及时更新了临床研究结果,特别关注神经精神后遗症的发病机制,并确定了为长期COVID-19制定有效治疗策略的潜在关键靶点。此外,我们介绍了福尔摩沙长期COVID多中心研究(FOCuS),该研究旨在将炎症理论应用于COVID后抑郁和焦虑的发病机制以及心理社会和营养治疗。